Molina Healthcare Inc (MOH)

Molina Healthcare Inc's Q·Score is 4.8/10 (Bearish), reflecting its current fundamentals, analyst data, and valuation metrics. Valuation metrics in line with sector peers. Key area to monitor: revenue declining 4% year-over-year. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.

The consensus price target for MOH is $186.63, based on ratings from 16 Wall Street analysts. This is 4.9% above the current price of $177.87. Price targets are forward-looking estimates and not guarantees of future performance.

Molina Healthcare Inc (MOH) scores favorably on valuation metrics relative to sector peers and analyst targets. Its forward P/E ratio stands at 19.4×.

Molina Healthcare Inc's next earnings report is expected on approximately July 22, 2026.

Molina Healthcare Inc has a net profit margin of 0.4%, which is positive but relatively thin. Its gross margin stands at 8.9%, reflecting a more cost-intensive business model.

Molina Healthcare Inc is reporting revenue declining 4.3% year-over-year. However, earnings declined 95.0%, which warrants monitoring.

Molina Healthcare Inc has a debt-to-equity ratio of 0.97×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 1.63×, indicating comfortable short-term liquidity.